3P BIOTECH NORWAY AS: årsregnskap 2017 vs 2016
Grew 2965% on revenue, slipped into loss
approved 2018-03-20; registry 2018-03-22; journal 2018 243185
Summary
What changed
Comparing Årsregnskap 2017 with 2016 for 3P BIOTECH NORWAY AS. Revenue 1 194 NOK → 36.6k NOK (+2965.3%). Net result +123.9k NOK → -18.3k NOK. Equity 494.5k NOK → 476.2k NOK.
On the constructive side: revenue rose; cash rose. Pressures included: fell into a net loss; equity eroded.
Also worth watching: paid-in equity reduced; cogs fell. All figures are taken from the published annual accounts for 3P BIOTECH NORWAY AS.
At a glance
Scorecard
What improved
-
↑
Revenue rose
Operating income / revenue moved from 1 194 NOK to 36.6k NOK (+2965.3% YoY). Calculated
-
↑
Cash rose
Bank deposits 5 237 NOK → 338.6k NOK (+6364.6% YoY). Calculated
What deteriorated
-
↓
Fell into a net loss
Net result flipped from 123.9k NOK profit to a loss of 18.3k NOK. Calculated
-
↓
Equity eroded
Book equity 494.5k NOK → 476.2k NOK (equity ratio 65.5% → 289.0%). Calculated
Things to notice
-
·
Paid-in equity reduced
Paid-in equity fell 494.5k NOK → 476.2k NOK — check capital reduction, conversion, or reclassification. Interpretation
-
·
COGS fell
COGS / varekostnad 55.9k NOK → 15.6k NOK (-72.0% YoY). Calculated